Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Eukaryotic Gene Expression
Импакт фактор: 1.841 5-летний Импакт фактор: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Печать: 1045-4403
ISSN Онлайн: 2162-6502

Выпуски:
Том 29, 2019 Том 28, 2018 Том 27, 2017 Том 26, 2016 Том 25, 2015 Том 24, 2014 Том 23, 2013 Том 22, 2012 Том 21, 2011 Том 20, 2010 Том 19, 2009 Том 18, 2008 Том 17, 2007 Том 16, 2006 Том 15, 2005 Том 14, 2004 Том 13, 2003 Том 12, 2002 Том 11, 2001 Том 10, 2000 Том 9, 1999 Том 8, 1998 Том 7, 1997 Том 6, 1996 Том 5, 1995 Том 4, 1994

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v20.i1.30
pages 35-50

Strategies for Regeneration of Heart Muscle

Jacques P. Guyette
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA 01609 USA
Ira S. Cohen
Department of Physiology and Biophysics, Stony Brook University, Stony Brook, NY 11794 USA
Glenn R. Gaudette
Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA 01609

Краткое описание

Regenerative medicine has emerged to the forefront of cardiac research, marrying discoveries in both basic science and engineering to develop viable therapeutic approaches for treating the diseased heart. Signifi cant advancements in gene therapy, stem cell biology, and cardiomyoplasty provide new optimism for regenerating damaged myocardium. Exciting new strategies for endogenous and exogenous regeneration have been proposed. However, questions remain as to whether these approaches can provide enough new myocyte mass to sufficiently restore mechanical function to the heart. In this article, we consider the mechanisms of endogenous cardiomyocyte regeneration and exogenous cell differentiation (with respect to myoblasts, stem cells, and induced pluripotent cells being researched for cell therapies). We begin by reviewing some of the cues that are being harnessed in strategies of gene/cell therapy for regenerating myocardium. We also consider some of the technical challenges that remain in determining new myocyte generation, tracking delivered cells in vivo, and correlating new myocyte contractility with cardiac function. Strategies for regenerating the heart are being realized as both animal and clinical trials suggest that these new approaches provide short-term improvement of cardiac function. However, a more complete understanding of the underlying mechanisms and applications is necessary to sustain longer-term therapeutic success.


Articles with similar content:

Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs
Critical Reviews™ in Biomedical Engineering, Vol.43, 2015, issue 5-6
Bo Wang, Bryn Brazile, Andrew Claude, Jianjun Guan, Yi Hong, Ge Zhang, J. Ryan Butler, Sourav S. Patnaik, Jun Liao
Oncogenic RAS: From Its Activation to Its Direct Targeting
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 3-4
Apostolos Zaravinos
Airway Macrophage and Dendritic Cell Subsets in the Resting Human Lung
Critical Reviews™ in Immunology, Vol.38, 2018, issue 4
Vineet Indrajit Patel, Jordan Patrick Metcalf
Molecular Signaling in Bone Regeneration
Critical Reviews™ in Eukaryotic Gene Expression, Vol.17, 2007, issue 2
Dafna Benayahu, A. Yaffe, I. Binderman, H. Bahar
The Contribution of DNA Base Damage to Human Cancer Is Modulated by the Base Excision Repair Interaction Network
Critical Reviews™ in Oncogenesis, Vol.14, 2008, issue 4
Katarzyna D. Arczewska, Hilde Nilsen, Katerina Michalickova, Ian M. Donaldson